Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study
- PMID: 1979431
- DOI: 10.1016/0306-4522(90)90389-l
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study
Abstract
Parkinson's disease is associated with a massive loss in melanized dopaminergic neurons in the substantia nigra resulting in a severe striatal dopaminergic denervation. The hyperactivity which develops in the remaining striatal dopaminergic terminals may be related to an increased rate of tyrosine hydroxylation. This could be related to changes in the level of expression of the gene coding for tyrosine hydroxylase. Thus, the detection of tyrosine hydroxylase messenger RNA was looked for at cellular levels by in situ hybridization histochemistry. Image analysis shows that the hybridization signal was significantly reduced in the surviving neurons when compared to control. The subnormal tyrosine hydroxylase messenger RNA content may express a change in level of tyrosine hydroxylase gene transcription, possibly in relation to sustained suffering of the neurons still present at late stages of the disease.
Similar articles
-
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.J Neurochem. 1993 Sep;61(3):1024-34. doi: 10.1111/j.1471-4159.1993.tb03616.x. J Neurochem. 1993. PMID: 8103078
-
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.Brain Res. 1993 Mar 26;606(2):341-5. doi: 10.1016/0006-8993(93)91005-d. Brain Res. 1993. PMID: 8098254
-
Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons.Neuroscience. 1992 Jul;49(2):297-305. doi: 10.1016/0306-4522(92)90097-l. Neuroscience. 1992. PMID: 1359452
-
Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease.J Neurol. 2000 Apr;247 Suppl 2:II25-35. doi: 10.1007/pl00007757. J Neurol. 2000. PMID: 10991662 Review.
-
Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.J Neural Transm Suppl. 2007;(72):113-20. doi: 10.1007/978-3-211-73574-9_14. J Neural Transm Suppl. 2007. PMID: 17982884 Review.
Cited by
-
Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?Biomolecules. 2015 Jul 16;5(3):1467-79. doi: 10.3390/biom5031467. Biomolecules. 2015. PMID: 26193328 Free PMC article. Review.
-
Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons.Mol Pharmacol. 2008 Jun;73(6):1816-28. doi: 10.1124/mol.107.043968. Epub 2008 Mar 18. Mol Pharmacol. 2008. PMID: 18349104 Free PMC article.
-
Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.J Neurosci. 1997 Jan 15;17(2):765-73. doi: 10.1523/JNEUROSCI.17-02-00765.1997. J Neurosci. 1997. PMID: 8987798 Free PMC article.
-
The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.Acta Neuropathol. 2010 Aug;120(2):131-43. doi: 10.1007/s00401-010-0711-0. Epub 2010 Jun 20. Acta Neuropathol. 2010. PMID: 20563819 Free PMC article. Review.
-
Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations.bioRxiv [Preprint]. 2024 Jun 3:2024.06.02.596989. doi: 10.1101/2024.06.02.596989. bioRxiv. 2024. PMID: 38895239 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
